IMDELLTRA

Indicated For

extensive-stage small cell lung cancer, ES-SCLC

About This Medication

# Amgen SupportPlus Patient Guide: How to Get IMDELLTRA (tarlatamab-dlle) at Low or No Cost IMDELLTRA (tarlatamab-dlle) is a prescription medication used to treat certain types of extensive-stage small cell lung cancer in adults who have previously received platinum-based chemotherapy. The **Amgen SupportPlus** program, offered by manufacturer **Amgen**, provides financial assistance primarily through its **Co-Pay Program** to help eligible patients reduce out-of-pocket costs for this therapy.[1][3][4] ## About IMDELLTRA (tarlatamab-dlle) IMDELLTRA is a targeted immunotherapy known as a bispecific T-cell engager (BiTE). It works by binding to cancer cells and activating the patient's T-cells to attack and destroy them. Administered via intravenous infusion, typically in a clinical setting, it requires careful monitoring due to potential side effects like cytokine release syndrome (CRS), neurologic toxicities, and infections. Always consult your healthcare provider for personalized advice on its use, dosing, and risks. This guide focuses on accessing the drug affordably through Amgen's support programs.[1][3] ## Who Qualifies for Amgen SupportPlus? The flagship **Amgen SupportPlus Co-Pay Program** is designed for patients with **commercial or private insurance** (not government insurance like Medicare or Medicaid). Key eligibility points include: - Valid prescription for IMDELLTRA. - Residence in the U.S. or U.S. territories (e.g., Puerto Rico, Guam).[2][7] - **No income eligibility requirements** – unlike many assistance programs, this co-pay help is available regardless of household income.[1][4] Eligible patients may pay **as little as $0 out-of-pocket** per dose or cycle, with assistance applied toward deductibles, co-insurance, and co-pays. Program maximums and other criteria apply; full terms are at AmgenSupportPlus.com/copay.[1][4][8] Amgen SupportPlus also offers broader services like **Patient Navigator Program** and **Nurse Partner services** for treatment support, insurance verification, and adherence help. These may collect household income data voluntarily but do not restrict co-pay access based on it.[2][5] **Note:** If you have government insurance, you may not qualify for the co-pay program but could explore other Amgen resources or independent foundations.[1] ## Income Eligibility Breakdown Amgen SupportPlus Co-Pay Program has **no income thresholds**. This makes it accessible to a wide range of patients. For context, here's a comparison with typical patient assistance programs (PAPs): | Household Size | Typical PAP (400-500% FPL) | Amgen SupportPlus Co-Pay | |----------------|----------------------------|--------------------------| | Individual | ~$60,000-$75,000/year | **No limit** | | Couple | ~$80,000-$100,000/year | **No limit** | | Family of 3 | ~$100,000-$125,000/year | **No limit** | | Family of 4 | ~$120,000-$150,000/year | **No limit** | FPL = Federal Poverty Level (2026 guidelines approximate). Amgen's lack of income caps is a key benefit for commercially insured patients.[1][2][4] ## Insurance Requirements - **Commercial/Private Insurance Required:** The co-pay program is for patients with employer-sponsored, marketplace, or other non-government plans.[1][4][8] - **Medicare/Medicaid Ineligible:** Government-insured patients generally cannot use the co-pay card.[1] - **Insurance Verification:** Amgen can check your benefits via forms or calls. Have your insurance card ready.[1][8][9] If uninsured or underinsured, contact Amgen for alternative options like free drug programs (availability varies).[3] ## Step-by-Step Application Process Applying is straightforward with **multiple methods**. Expect instant digital activation for co-pay cards.[1][6] 1. **Check Eligibility Online:** Visit AmgenSupportPlus.com/copay or copay.amgensupportplus.com/patient/enroll. Complete the 4-step process: eligibility check, personal info, doctor/site of care, and activation.[1][4][6] 2. **Gather Information:** - Full name, DOB, address, phone, email. - Insurance details (member ID, group number). - Prescriber info (name, NPI, contact).[2][6][7] 3. **Enroll by Phone:** Call **(866) 264-2778** (Mon-Fri, 9am-8pm ET) or **(844) 992-6436** for support. Patient Navigators assist with enrollment and questions.[1][2][4] 4. **For Providers:** Doctors can submit Patient Request Form (fax to 1-833-626-5384) or Insurance Verification Form (fax to 1-877-877-6542 or online at myAmgenPortal.com).[7][8][9] 5. **Activate Co-Pay Card:** Receive a virtual card instantly. Provide card details to your doctor's office or specialty pharmacy at infusion.[1][10] 6. **Consent to Data Processing:** Required for Navigator Program; review and sign during enrollment.[2][5] ## Timeline and Delivery - **Enrollment:** Instant online; phone same-day assistance.[1][6] - **Approval:** Co-pay cards activate immediately upon eligibility confirmation; no lengthy processing.[1][4] - **Delivery:** IMDELLTRA is infused at a clinic or hospital. Co-pay savings apply at point-of-service. No home delivery specified; coordinate with your provider.[1][3] Refills use the same card automatically. Track usage via your account.[1] ## Alternatives if Denied or Ineligible - **Appeal:** Contact Amgen SupportPlus for review.[1] - **Independent Foundations:** Search PAN Foundation, Patient Access Network, or CancerCare for grants. - **Free Drug Program:** Ask Amgen about patient assistance for uninsured (call to confirm for IMDELLTRA).[3] - **State Programs:** Check Medicaid extra help or state pharmaceutical aid. - **Biosimilars:** None currently available for IMDELLTRA.[provided data] Discuss with your oncologist for trial access or compassionate use. ## Important Disclaimer This guide is for informational purposes only and based on publicly available program details as of 2026. Eligibility, terms, and availability can change; always verify at AmgenSupportPlus.com or by calling (866) 264-2778. Amgen does not guarantee coverage. Consult your healthcare provider or financial counselor. Not affiliated with government programs or insurers. Word count: 1028.

Program information last verified: March 30, 2026